Quantitative aspects of drug and toxicant-induced astrogliosis.
A universal cellular reaction to damage of the CNS is hypertrophy of astrocytes. The hallmark of this response, often termed 'reactive gliosis', is the enhanced expression of the major intermediate filament protein of astrocytes, glial fibrillary acidic protein (GFAP). This latter observation suggests that increased synthesis of GFAP would occur in response to diverse neurotoxic insults. To investigate this possibility, prototype neurotoxicants were administered to experimental animals and the effects of these agents on the tissue content of GFAP was determined by immunoassay. Assays of GFAP were found to reveal dose-, time- and region-dependent patterns of neurotoxicity at toxicant dosages below those that cause light microscopic evidence of cell loss or damage. Moreover, the temporal and regional increments in GFAP correspond to the temporal and regional patterns of argyrophilia, as revealed by the cupric silver degeneration stain of de Olmos. Our findings indicate that assays of GFAP represent a sensitive, simple and quantitative approach for evaluation of nervous system damage. Combining this indirect yet quantitative indicator of neurotoxicity with more traditional neuroanatomical endpoints, should augment the armamentarium of techniques useful for detection and characterization of neurotoxicity.
O'Callaghan
J P
JP
Neurotoxicology Division, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.
Jensen
K F
KF
Miller
D B
DB
D000818:Animals; D002491:Central Nervous System Agents / Q000633:toxicity*; D005904:Glial Fibrillary Acidic Protein / Q000032:analysis; D005911:Gliosis / Q000139:chemically induced*; D007118:Immunoassay; D007150:Immunohistochemistry; D012015:Reference Standards; D015203:Reproducibility of Results
D002491:Central Nervous System Agents; D005904:Glial Fibrillary Acidic Protein